High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-47439-3.pdf
Reference60 articles.
1. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).
2. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America 98, 10869–10874 (2001).
3. Howlader, N. et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. Journal of the National Cancer Institute 106 (2014).
4. Parise, C. A. & Caggiano, V. Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers. Journal of cancer epidemiology 2014, 469251 (2014).
5. Wu, V. S., Kanaya, N., Lo, C., Mortimer, J. & Chen, S. From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer? The Journal of steroid biochemistry and molecular biology 153, 45–53 (2015).
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biomarker-based immunotherapy in breast cancer;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025
2. Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy;Human Genomics;2023-05-18
3. ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth;Cell Death & Disease;2022-08-06
4. Isolated MLH1 Loss by Immunohistochemistry Because of Benign Germline MLH1 Polymorphisms;JCO Precision Oncology;2022-08
5. Phase-Separated Subcellular Compartmentation and Related Human Diseases;International Journal of Molecular Sciences;2022-05-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3